1. Home
  2. AGCO vs MDGL Comparison

AGCO vs MDGL Comparison

Compare AGCO & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGCO Corporation

AGCO

AGCO Corporation

HOLD

Current Price

$113.48

Market Cap

8.5B

Sector

Industrials

ML Signal

HOLD

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$482.19

Market Cap

12.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGCO
MDGL
Founded
1990
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
12.5B
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
AGCO
MDGL
Price
$113.48
$482.19
Analyst Decision
Hold
Strong Buy
Analyst Count
10
14
Target Price
$112.10
$597.54
AVG Volume (30 Days)
704.4K
312.8K
Earning Date
02-05-2026
02-25-2026
Dividend Yield
1.02%
N/A
EPS Growth
121.88
N/A
EPS
5.02
N/A
Revenue
$10,049,100,000.00
$740,640,000.00
Revenue This Year
N/A
$435.62
Revenue Next Year
$3.00
$52.67
P/E Ratio
$22.66
N/A
Revenue Growth
N/A
864.21
52 Week Low
$73.79
$265.00
52 Week High
$121.16
$615.00

Technical Indicators

Market Signals
Indicator
AGCO
MDGL
Relative Strength Index (RSI) 59.77 31.14
Support Level $109.35 $483.55
Resistance Level $115.58 $511.94
Average True Range (ATR) 3.60 23.79
MACD 0.38 -6.68
Stochastic Oscillator 66.10 12.67

Price Performance

Historical Comparison
AGCO
MDGL

About AGCO AGCO Corporation

Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealer and distribution locations and reach into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its unconsolidated joint venture with Rabobank of the Netherlands.

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

Share on Social Networks: